Curt Herberts is the founder of Senti Biosciences. Senti Biosciences has raised $105M in total funding. Latest round: Series B. Backed by Spark Therapeutics.
Curt Herberts is a biotech executive who previously served as President and Chief Operating Officer at Senti Biosciences. During his time there, he oversaw a $105 million Series B financing and a gene therapy AAV deal, and later announced the company's business combination with Dynamics Special Purpose Corp., leading to its public debut on Nasdaq. He has also held the same role at Kriya Therapeutics, Inc.
Full founder directory · Investor directory · Company funding database · Fundraising library